- Press Release -

Rockville, Md. The global drug eluting balloon catheter market is set for robust growth through 2022, according to Fact.MR, on the back of strong results in cardiovascular and peripheral artery procedures. The devices are also proving useful for patients unable to undergo percutaneous coronary intervention, widening their addressable base and prompting manufacturers to lift production capacity.

Europe leads the market, coronary artery procedures dominate use, hospitals account for most consumption, and nylon is the leading material. Rising cardiovascular disease and a growing volume of cardiology interventions underpin the demand.

Indications, Settings and Materials

Coronary artery disease is the dominant indication at more than two-thirds of revenue. Hospitals lead among end users at close to 73% of revenue, as the preferred setting for coronary artery and restenosis procedures. By raw material, nylon-based catheters hold about 54.1% of revenue, with more than US$ 244 Mn expected to sell by 2022.

Europe retains its dominant position and expands at a 20.5% CAGR through the forecast period, while Asia Pacific excluding Japan also posts robust growth.

Clinical Demand Drives Growth

The market runs on rising need and better access. Growing cardiovascular disease and more frequent cardiology interventions lift the base demand, while improved reimbursement, an ageing population and higher healthcare spending reinforce it. New-generation devices and heavier R&D investment are opening further opportunities as manufacturers work to widen the range of uses.

Suppliers and Their Playbook

The field brings together cardiovascular device specialists and large medical technology firms.

• Medtronic Plc., Cook Medical INC, Abbott Laboratories, Jotech GmbH, Terumo Corporation, Tokai Medical Products Inc., B. Braun Melsungen AG, Cardionovum GmbH, Cordis Corporation, Meril Life Sciences Pvt Ltd, MicroPort Scientific Corporation, Boston Scientific Corporation, and BIOTRONIK SE & Co. KG are among the key players in the report.

Reading the Market for Decisions

For device makers, growth favours cost-effective, next-generation devices that broaden clinical use. Investors get a fast-growing, specialised market with a firm clinical tailwind. Procurement and hospital teams can plan around coronary applications carrying volume, nylon devices leading material, and Europe offering the largest opportunity through 2022.

About the Report

Fact.MR's study covers the global drug eluting balloon catheter market for the 2017 to 2022 forecast period, with segmentation by raw material, indication, end user and region. It sizes each segment, maps the competitive field, and weighs the clinical forces shaping demand. Further detail is available in the drug eluting balloon catheter market report.

About Fact.MR

Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. The firm is known for its syndicated research, custom research and consulting solutions, helping clients make decisions on demand, competition, investment, procurement and future growth.